Recruiting

Positive Peers

Sponsor:

MetroHealth Medical Center

Code:

NCT06388109

Conditions

HIV Infections

Eligibility Criteria

Sex: All

Age: 13 - 34

Healthy Volunteers: Not accepted

Interventions

Positive Peers mobile app

Study Details

Brief summary:

The goal of this clinical trial is to learn if the Positive Peers mobile app intervention increases rates of viral suppression in young (13-34 y/o) persons with HIV.

Does use of the Positive Peers app improve viral suppression among young minority persons with HIV? What user characteristics are associated with a) viral suppression, b) retention in care, and c) perceived HIV-related stigma?

Participants will:

  • download the mobile app onto their personal smartphone
  • Use the mobile app as they find useful
  • complete online surveys at enrollment, 3 mo, 6, mo, 9 mo and 12 months.

Conditions

HIV Infections

Study ID

NCT06388109

Start date

Jun 3, 2024

Status verified date

Aug, 2026

Completion date

Nov, 2027

Anticipated

Primary completion date

May, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 13 - 34

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • HIV+
  • Identifies as either a racial, ethnic, sexual or gender minority or a cisgender female and

One of the following:

  • Newly diagnosed within last 12 months
  • Out of care (greater than 6 months between any two HIV provider visits in last 24 months)
  • Not virally suppressed (any viral load > 200 copies in last 24 months)
  • Has a working smartphone
  • Functional English ability

Exclusion Criteria:

  • prior use of Positive Peers mobile app

Study Design

Enrollment

250 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Supportive Care

Interventions and Outcome Measures

Arms

experimental: Immediate Start

Participants in the immediate start arm will download and begin use of the Positive Peers app at the enrollment visit.

active comparator: Delayed Start

Participants in the delayed start arm will download and begin use of the Positive Peers app 6 months after enrollment

no intervention: Observational Cohort

Participants in the observational cohort have declined participation in the clinical trial but agree to do the baseline survey and have medical outcomes data recorded.

Interventions

Positive Peers mobile app

Positive Peers is a multifunctional mobile app using a mind, body, spirit theme aimed to improve HIV care outcomes.

Primary outcome measure

  • Viral suppression [ Time Frame: 6 months ]

Central Contacts and Locations

Central contacts

Jennifer McMillen-Smith, LISW-S

2167784051jmsmith@metrohealth.org

Ann Avery, MD

aavery@metrohealth.org

Locations

Northeast Valley Health Corporation

Recruiting

Van Nuys, California, United States, 91405

Contacts

Noel Barragan

(818) 988-6335noelbarragan@nevhc.org

Principal Investigator:

Herberth Osorio, MPH

Infectious Disease Practice- Rutgers University

Recruiting

Newark, New Jersey, United States, 07103

Contacts

Sireesha Kada

sk2885@njms.rutgers.edu

Principal Investigator:

Shoba Swaminathan, MD

Equitas Health

Recruiting

Cincinnati, Ohio, United States, 45206

Contacts

Tania Slack-Peterson

TaniaSlack@equitashealth.com

Principal Investigator:

Kelly Wesp, PhD

St. Jude Children's Research Hospital

Recruiting

Memphis, Tennessee, United States, 38105

Contacts

Megan McWain, MS

901-595-7564megan.mcwain@stjude.org

Principal Investigator:

Megan Wilkins, PhD

Thomas Street Clinic

Recruiting

Houston, Texas, United States, 77004-8004

Contacts

Ernesto Linares Pineda

Ernesto.LinaresPineda@bcm.edu

Principal Investigator:

Shital Patel, MD

UW Madison Clinic at Harborview

Recruiting

Seattle, Washington, United States, 98104

Contacts

Amari Perry

amarip@uw.edu

Principal Investigator:

H Nina Kim, MD, MPH

More Information

Sponsor

MetroHealth Medical Center

Last update posted

Aug 18, 2026

Last verified

Aug, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by MetroHealth Medical Center on 2026-08-18.